Regenxbio RGNX
NASDAQ RGNX
$6.68 -0.49 (-6.83%)
At close: Oct 23, 2026 · 4:00 PM EDT

Regenxbio (RGNX) Sale and Maturity of Investments (2016 - 2025)

Updated

Analysis

Regenxbio (RGNX) Sale and Maturity of Investments (2016 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Regenxbio 361.82 Mn -571.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 100.86 Mn
Sep 30, 2025 82.24 Mn
Jun 30, 2025 71.10 Mn
Mar 31, 2025 64.92 Mn
Dec 31, 2024 51.79 Mn
Sep 30, 2024 86.78 Mn
Jun 30, 2024 82.73 Mn
Mar 31, 2024 68.93 Mn
Dec 31, 2023 53.74 Mn
Sep 30, 2023 56.25 Mn
Jun 30, 2023 107.59 Mn
Mar 31, 2023 67.91 Mn
Dec 31, 2022 44.14 Mn
Sep 30, 2022 72.12 Mn
Jun 30, 2022 37.03 Mn
Mar 31, 2022 49.86 Mn
Dec 31, 2021 33.73 Mn
Sep 30, 2021 49.92 Mn
Jun 30, 2021 36.01 Mn
Mar 31, 2021 50.47 Mn
API Access

Regenxbio Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=RGNX&period=max&api_key=YOUR_API_KEY